Loading live market data…

China Medicine Corp.

OTC:CHME

$0.0205 USD

$0 (0.0%)

Volume
131.5K
Average Volume
3.97K
Market Capitalization
$486.1K
P/E Ratio
0.19
Dividend Yield
0.00%
Price Target
$
Year High
$0.04
Year Low
$0.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$2.10

Industry, Sector & symbol

Stock Exchange OTC
CEO Senshan Yang
Industry Medical - Pharmaceuticals
Sector Healthcare
Current Symbol CHME
CUSIP 169491107
CIK None
Web https://www.cmc621.com
Phone 86 20 8739 1718
Currency USD
Employees 281
Country CN

Liquidity

Debt-to-Equity Ratio 0.21
Payout Ratio 0.00
Current Ratio 2.10
Quick Ratio 1.91
Cash Ratio 0.03

Sales & Book Value

Annual Sales $64.75M
Price / Sales 0.01
Cash Flow 0.87
Price / Cash Flow 0.04
Price / Book 0.01

Price Target and Rating

Average Stock Price Forecast $
High Stock Price Forecast $
Low Stock Price Forecast $
Forecast Upside/Downside %
Consensus Rating N/A
Rating Score(0-5) 0
Research Coverage 0 Analysts

Profitability

EPS (Most Recent Fiscal Year) $0.11
Trailing P/E Ratio 0.19
PEG Ratio 0.00
P/E Growth 0.00
Net Income $1.72M
Net Margin 2.65%
Pretax Margin 7.65%
Return on Equity 3.91%
Return on Assets 2.57%

Financials Score

AltmanZ Score 1.81
Piotroski Score 6.00
Working Capital 85.75M
Total Assets 134.04M
Ebit 11.7M
Market Cap 486.1K
Total Liabilities 56.12M

Poll Results

About China Medicine Corp. (OTC:CHME) Stock

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and ... cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Frequently Asked Questions

What is the current China Medicine Corp. (CHME) stock price?

China Medicine Corp.(OTC:CHME) stock price is $0.0205 in the last trading session. During the trading session, CHME stock reached the peak price of $0.0426 while $0.0005 was the lowest point it dropped to. The percentage change in CHME stock occurred in the recent session was 0.0% while the dollar amount for the price change in CHME stock was $0.

CHME's industry and sector of operation?

The OTC listed CHME is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.

Who are the executives of CHME?

Senshan Yang | Chairman, Chief Executive Officer & Chairman of Guangzhou Konzern Medicine Co., Ltd
Chi Fung | Chief Financial Officer
Huizhen Yu | Controller
|
|

How many employees does CHME have?

Number of CHME employees currently stands at 281. CHME operates from 2/F, Guangri Tower, Guangzhou, GD 510006, CN.

Link for CHME official website?

Official Website of CHME is: https://www.cmc621.com

How do I contact CHME?

CHME could be contacted at phone #86 20 8739 1718 and can also be accessed through its website. CHME operates from 2/F, Guangri Tower, Guangzhou, GD 510006, CN.

How many shares of CHME are traded daily?

The average number of CHME shares traded daily for last 3 months was 3.97K.

What is the market cap of CHME currently?

The market value of CHME currently stands at $486.1K with its latest stock price at $0.0205